Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 16:05 ET | Source: electroCore, Inc.

electroCore Announces First Quarter 2025 Financial Results

First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of...
April 30, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for...
April 17, 2025 08:00 ET | Source: electroCore, Inc.

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the...
April 16, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the Planet MicroCap Showcase

ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
April 03, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times

ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one...
April 01, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
March 31, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Extends VA Contract for Five Years

ROCKAWAY, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that electroCore has received a...
March 12, 2025 16:05 ET | Source: electroCore, Inc.

electroCore Announces Full Year 2024 Financial Results

Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTM in the United States Department of Veteran...
March 06, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial...
March 05, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at Upcoming Investor Conferences

ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...

Next Page keyboard_arrow_right